Abstract
The reverse seroconversion to hepatitis B virus infection has been sporadically described in onco-haematological patients receiving cytotoxic therapy or allogeneic bone marrow transplantation and can be associated with the development of acute icteric hepatitis. We present a male HBsAg-negative, anti-HBc-positive patient with Hairy Cell Leukemia who developed acute B hepatitis more than 1 year after the last course of 2-CdA and 6 months after splenectomy, while the patient was receiving therapy with αIFNr. The acute B hepatitis promptly responded to lamivudine therapy followed by viral clearance.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Orlando, R., Tosone, G., Tiseo, D. et al. Severe Reactivation of Hepatitis B Virus Infection in a Patient with Hairy Cell Leukemia: Should Lamivudine Prophylaxis be Recommended to HBsAg-Negative, Anti-HBc-Positive Patients?. Infection 34, 282–284 (2006). https://doi.org/10.1007/s15010-006-4150-8
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s15010-006-4150-8